tiprankstipranks
Horizon Therapeutics (DE:HPR)
FRANKFURT:HPR

Horizon Therapeutics (HPR) Stock News & Sentiment

0 Followers
Amgen price target raised to $320 from $265 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $320 from $265 at Wells Fargo
6M ago
Amgen upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Amgen upgraded to Outperform from Market Perform at Leerink
6M ago
Amgen completes acquisition of Horizon Therapeutics
PremiumThe Fly
Amgen completes acquisition of Horizon Therapeutics
7M ago
Horizon Pharma put volume heavy and directionally bearish
PremiumThe Fly
Horizon Pharma put volume heavy and directionally bearish
7M ago
Horizon Therapeutics announces acquisition by Amgen approved in Ireland
PremiumThe Fly
Horizon Therapeutics announces acquisition by Amgen approved in Ireland
7M ago
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
PremiumThe Fly
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
7M ago
Horizon Therapeutics announces new data on TEPEZZA treatment
PremiumThe Fly
Horizon Therapeutics announces new data on TEPEZZA treatment
7M ago
More HZNP News >

News Score - Last 7 Days

Neutral
DE:HPR
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.25 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:HPR’s Media Buzz Sentiment?
1 articles about DE:HPR were published this week. In an average week, 6.25 articles are published.
    What is DE:HPR’s weekly average amount of articles?
    In an average week, 6.25 articles about DE:HPR are published.
      What is DE:HPR’s News Sentiment?
      50% of articles about DE:HPR were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        OPRXOptimizeRx
        HALOHalozyme
        PROKProKidney
        JNJJohnson & Johnson
        SAVACassava Sciences
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis